COVID-19 Vaccine: Pfizer Delays Vaccine Deliveries To 8 European Nations: Spain
Covid-19 Vaccine: The Spanish branch of Pfizer informed Madrid of the delay in shipments to the eight nations due to a "problem in the loading and shipment process" at its plant in Belgium, the health ministry said.
Pfizer has postponed the delivery of new batches of its coronavirus vaccine to eight European nations including Spain, the Spanish health ministry said Monday, a day after the EU began its immunisation campaign.
The Spanish branch of Pfizer informed Madrid on Sunday night of the delay in shipments to the eight nations due to a "problem in the loading and shipment process" at its plant in Belgium, the health ministry said in a statement.
It did not specify which European nations aside from Spain were affected.
Pfizer has informed the ministry that the problem "was already resolved" but the next delivery of vaccines "will be a few hours late" and arrive in Spain on Tuesday, a day later than expected, the statement said.
Asked about the delay during an interview with radio Ser, Health Minister Salvador Illa said it was due to a problem "linked to the control of the temperature" of the shipments which was "apparently fixed".
The vaccine must be stored at ultra-low temperatures of about -70 degrees Celsius (-112 Fahrenheit) before being shipped to distribution centres in specially designed cool boxes filled with dry ice.
Once out of ultra-low temperature storage, the vaccine must be kept at 2 Celsius to 8 Celsius to remain effective for up to five days.
Spain is scheduled to received 350,000 doses of the Pfizer-BioNTech coronavirus vaccine per week over the next three months.
Most European Union nations began their immunisation campaigns against the virus this weekend with the Pfizer-BioNTech jab, beginning with the elderly, health care workers and politicians.
The Spanish branch of Pfizer informed Madrid on Sunday night of the delay in shipments to the eight nations due to a "problem in the loading and shipment process" at its plant in Belgium, the health ministry said in a statement.
It did not specify which European nations aside from Spain were affected.
Pfizer has informed the ministry that the problem "was already resolved" but the next delivery of vaccines "will be a few hours late" and arrive in Spain on Tuesday, a day later than expected, the statement said.
Asked about the delay during an interview with radio Ser, Health Minister Salvador Illa said it was due to a problem "linked to the control of the temperature" of the shipments which was "apparently fixed".
The vaccine must be stored at ultra-low temperatures of about -70 degrees Celsius (-112 Fahrenheit) before being shipped to distribution centres in specially designed cool boxes filled with dry ice.
Once out of ultra-low temperature storage, the vaccine must be kept at 2 Celsius to 8 Celsius to remain effective for up to five days.
Spain is scheduled to received 350,000 doses of the Pfizer-BioNTech coronavirus vaccine per week over the next three months.
Most European Union nations began their immunisation campaigns against the virus this weekend with the Pfizer-BioNTech jab, beginning with the elderly, health care workers and politicians.
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
